Linda Owers Narhi

Linda Owers Narhi is a prominent inventor based in Camarillo, CA (US). She has made significant contributions to the field of biopharmaceuticals, holding a total of 3 patents. Her work focuses on innovative solutions that enhance cellular functions and address inflammatory responses.

Latest Patents

One of her latest patents involves keratinocyte growth factor-2 products. This invention concerns variants and chemical derivatives of keratinocyte growth factor-2 (KGF-2) protein. The patent also discloses nucleic acid molecules encoding such variants, as well as methods for using these variants and chemical derivatives to stimulate epithelial cell proliferation. Another notable patent is related to anti-inflammatory CD14 peptides. This invention pertains to anti-inflammatory peptides based on specific peptide regions of CD14, which have potential therapeutic applications.

Career Highlights

Linda has built a successful career in the biopharmaceutical industry, working with Amgen Inc. Her expertise in protein engineering and peptide design has positioned her as a leader in her field. Her innovative approaches have led to advancements in treatments for various medical conditions.

Collaborations

Throughout her career, Linda has collaborated with esteemed colleagues, including Michael Levitt and Timothy David Osslund. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of groundbreaking technologies.

Conclusion

Linda Owers Narhi is a trailblazer in the biopharmaceutical sector, with a focus on innovations that improve health outcomes. Her contributions through her patents and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.